267
Participants
Start Date
August 31, 2005
Primary Completion Date
July 31, 2007
Study Completion Date
December 31, 2007
Trafermin (genetical recombination)
Kaken Investigational Site, Nagoya
Kaken Investigational Site, Chiba
Kaken Investigational Site, Matsudo
Kaken Investigational Site, Fukuoka
Kaken Investigational Site, Fukuoka
Kaken Investigational Site, Kitakyushu
Kaken Investigational Site, Mizuho
Kaken Investigational Site, Hiroshima
Kaken Investigational Site, Ishikari-gun
Kaken Investigational Site, Sapporo
Kaken Investigational Site, Morioka
Kaken Investigational Site, Kagoshima
Kaken Investigational Site, Yokohama
Kaken Investigational Site, Sendai
Kaken Investigational Site, Nagasaki
Kaken Investigational Site, Niigata
Kaken Investigational Site, Okayama
Kaken Investigational Site, Suita
Kaken Investigational Site, Tokushima
Kaken Investigational Site, Bunkyo-ku
Kaken Investigational Site, Chiyoda-ku
Kaken Investigational Site, Machida
Kaken Investigational Site, Sinjyuku-ku
Lead Sponsor
Kaken Pharmaceutical
INDUSTRY